Trial Profile
A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Co-Administration of FOV1101-00 (Cyclosporine 0.01% or 0.02%) and Prednisolone Acetate 0.12% (PredMild®) Compared to Prednisolone Acetate 1% Alone or Vehicle Alone in Patients With Mild Ongoing Ocular Allergic Inflammation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 May 2014
Price :
$35
*
At a glance
- Drugs Prednisolone/ciclosporin (Primary) ; Prednisolone acetate
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Fovea Pharmaceuticals
- 06 May 2014 New trial record